Nemonoxacin Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Nemonoxacin is a novel
nonfluorinated quinolone and broad-spectrum antibiotic for the
treatment of drug-resistant bacterial infections, including
methicillin-resistant Staphylococcus aureus (MRSA) and quinolone-
resistant MRSA as well as quinolone-resistant Streptococcus
pneumonia. The drug was originally discovered by Procter &
Gamble Pharmaceuticals (P&GP). It was codeveloped by
TaiGen Biotechnology for development in Asia and by Warner
Chilcott for development in the United States and Europe and
was first approved by the China Food and Drug Administration
(CFDA).
Nemonoxacin Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
